Advertisement

Idiopathic Basal Ganglia Calcifications and Parkinson's Disease

  • Xiaopeng Guo
    Affiliations
    Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing, China
    Search for articles by this author
  • Honglin Hao
    Affiliations
    Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing, China
    Search for articles by this author
  • Hao Xing
    Affiliations
    Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing, China
    Search for articles by this author
  • Yi Guo
    Correspondence
    Requests for reprints should be addressed to Yi Guo, Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
    Affiliations
    Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing, China
    Search for articles by this author
      A 57-year-old man presented to the Neurology Clinic with a 6-year history of progressive bilateral static tremor, bradykinesia, and gait initiation difficulty. His non-motor manifestations included constipation and pollakiuria. Initial levodopa test revealed excellent responsiveness, with Unified Parkinson's Disease Rating Scale scores improving from 57 to 14 points (75%). No signs of atrophy in the cerebrum, cerebellum, or brain stem were found on the magnetic resonance imaging. Parkinson's disease was clinically diagnosed. Computerized tomography of the head showed bilateral, symmetric, dense calcifications in the basal ganglia and cerebellum (FigureA). His serum calcium level was normal, and he had normal parathyroid functions. Whole exome sequencing was then performed, and a heterozygous variant in the SLC20A2 gene, c.1784C>T (p.Thr595Met), was suspected as the disease-causing gene mutation. Therefore, the combination of bilateral brain calcifications, normal phosphate-calcium metabolic function, and SLC20A2 gene mutation contributed to the final diagnosis of idiopathic basal ganglia calcifications (iBGC), or Fahr's disease.
      Figure
      Figure(A) Bilateral, symmetric, dense calcifications located in the basal ganglia and cerebellum (not shown) in a patient presenting with Parkinson disease, and (B) successful deep brain stimulation surgery with electrodes targeting the bilateral subthalamic nucleus.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Donzuso G
        • Mostile G
        • Nicoletti A
        • Zappia M
        Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.
        Neurol Sci. 2019; 40: 2251-2263
        • Nicolas G.
        • Pottier C.
        • Charbonnier C.
        • et al.
        Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification.
        Brain. 2013; 136: 3395-3407
        • Hsu SC
        • Sears RL
        • Lemos RR
        • et al.
        Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.
        Neurogenetics. 2013; 14: 11-22
        • Guo XX
        • Zou XH
        • Wang C
        • et al.
        Spectrum of SLC20A2, PDGFRB, PDGFB, and XPR1 mutations in a large cohort of patients with primary familial brain calcification.
        Hum Mutat. 2019; 40: 392-403
        • Zhan FX
        • Tian WT
        • Zhang C
        • et al.
        Primary familial brain calcification presenting as paroxysmal kinesigenic dyskinesia: genetic and functional analyses.
        Neurosci Lett. 2020; 714134543
        • Kogan M
        • McGuire M
        • Riley J
        Deep brain stimulation for Parkinson disease.
        Neurosurg Clin N Am. 2019; 30: 137-146